Fig. 3From: Investigating the genomic alteration improved the clinical outcome of aged patients with lung carcinomaAnalysis of mutations in EGFR, KRAS and TP53. A-I Correlation of patient clinical characteristics and the genetic alterations. J Progression free survival in 34 EGFR mutated patients with or without TP53 mutation. “Number at risk” is the total number of participants in the study exposed to the risk of outcome eventsBack to article page